Back to JPMORGAN CHASE & CO JPMORGAN CHASE & CO

AVIRAVIR
7 quarters

Position history for JPMORGAN CHASE & COJPMORGAN CHASE & CO's holdings in ATEA PHARMACEUTICALS INC

JPMORGAN CHASE & CO holds 945,918 shares of AVIR (ATEA PHARMACEUTICALS INC), worth $4.4M as of 2026-Q2. The position was increased (+0.6% shares). AVIR represents 0.0% of JPMORGAN CHASE & CO's portfolio.

Current Value

$4.4M

Current Shares

945,918

Total Value Change

+$3M

Total Shares Change

+536,659

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
945,918
+0.6%
$4.4M0.0%$4.65
27
2026-Q1
Decreased
940,157
-30.3%
$4.8M0.0%$4.82
0
2025-Q4
Increased
1.3M
+9.3%
$4.8M0.0%$3.55
29
2025-Q3
Increased
1.2M
+89.0%
$3.6M0.0%$2.92
42
2025-Q2
Decreased
652,661
-15.6%
$2.3M0.0%$3.45
0
2025-Q1
Increased
773,217
+88.9%
$2.3M0.0%$2.93
41
2024-Q4
New
409,259
-
$1.4M0.0%$3.33
35

Other major holders of AVIR: RA CAPITAL MANAGEMENT, L.P., ADAGE CAPITAL PARTNERS GP, L.L.C.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used